Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14522937rdf:typepubmed:Citationlld:pubmed
pubmed-article:14522937lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C0007134lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C2243049lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:14522937lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:14522937pubmed:issue18lld:pubmed
pubmed-article:14522937pubmed:dateCreated2003-10-2lld:pubmed
pubmed-article:14522937pubmed:abstractTextExpression profiling has demonstrated that transcriptomes of primary malignancies differ from those in normal tissue. It is unknown, however, whether there exist "surrogate" transcriptional markers in peripheral blood mononuclear cells (PBMCs) of patients with solid tumors. We identified transcripts expressed differentially between PBMCs from renal cell carcinoma patients and normal subjects, some of which appear to reflect specific immune responses of circulating cells. We also identified small sets of predictor genes distinguishing PBMCs from renal cell carcinoma patients and normal volunteers with high accuracy. The present findings have important implications for diagnosis and future clinical pharmacogenomic studies of antitumor therapies.lld:pubmed
pubmed-article:14522937pubmed:languageenglld:pubmed
pubmed-article:14522937pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14522937pubmed:citationSubsetIMlld:pubmed
pubmed-article:14522937pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14522937pubmed:statusMEDLINElld:pubmed
pubmed-article:14522937pubmed:monthSeplld:pubmed
pubmed-article:14522937pubmed:issn0008-5472lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:HidalgoManuel...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:LoganTheodore...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:HudesGaryGlld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:StadlerWalter...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:SlonimDonna...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:DutcherJanice...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:TrepicchioWil...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:TwineNatalie...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:StoverJennife...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:MarshallBonni...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:DukartGaryGlld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:DornerAndrew...lld:pubmed
pubmed-article:14522937pubmed:authorpubmed-author:BurczynskiMic...lld:pubmed
pubmed-article:14522937pubmed:issnTypePrintlld:pubmed
pubmed-article:14522937pubmed:day15lld:pubmed
pubmed-article:14522937pubmed:volume63lld:pubmed
pubmed-article:14522937pubmed:ownerNLMlld:pubmed
pubmed-article:14522937pubmed:authorsCompleteYlld:pubmed
pubmed-article:14522937pubmed:pagination6069-75lld:pubmed
pubmed-article:14522937pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:meshHeadingpubmed-meshheading:14522937...lld:pubmed
pubmed-article:14522937pubmed:year2003lld:pubmed
pubmed-article:14522937pubmed:articleTitleDisease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.lld:pubmed
pubmed-article:14522937pubmed:affiliationDiscovery Medicine, Wyeth Research, Cambridge, Massachusetts 02140, USA.lld:pubmed
pubmed-article:14522937pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14522937lld:pubmed